The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene.
In vivo there appears to be a marked association between oestrogen levels and the expression of the oxytocin (OT) gene in most tissues. Transfection and DNA-protein binding experiments using high levels of either oestrogen receptor (ER)alpha or ERbeta imply a direct interaction of these transcription factors with the multiple hormone response element (HRE) at approximately -160 from the transcription start site of the OT gene in most species. In an extensive set of experiments, we show, using both transfection and protein-DNA binding, that low to moderate amounts of either oestrogen receptor, while being able to interact directly with a classic oestrogen response element (ERE) fail to interact with the human OT -160 HRE. Instead, this element, similar to its bovine counterpart, has a high affinity for the orphan receptors steroidogenic factor 1 and chicken ovalbumin upstream promoter transcription factor. Second, the human and bovine OT promoter can be made artificially responsive towards oestrogen in a cotransfection system over-expressing ERalpha or ERbeta, but not in cells expressing natural levels of these steroid receptors. Interestingly, nuclear extracts from both ERalpha-positive MCF7 cells and ERalpha-negative MDA-MB231 cells both contain a transcription factor which binds specifically to both the hOT-HRE element and to a classic ERE, and which has orphan receptor-like binding properties rather than those of an oestrogen receptor. Together, these and other results suggest that oestrogen action in vivo on the OT gene in all species is more likely to involve a DNA-independent mechanism than classic direct interactions with dimeric oestrogen receptors.
Stedronsky
K
K
Institute for Hormone and Fertility Research, University of Hamburg, Hamburg, Germany.
Telgmann
R
R
Tillmann
G
G
Walther
N
N
Ivell
R
R
D000818:Animals; D051836:COUP Transcription Factors; D002417:Cattle; D002467:Cell Nucleus / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D004586:Electrophoresis; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D051717:Fushi Tarazu Transcription Factors; D018398:Homeodomain Proteins; D006728:Hormones / Q000502:physiology*; D006801:Humans; D010121:Oxytocin / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000502:physiology*; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear; D011960:Receptors, Estrogen / Q000378:metabolism; D011987:Receptors, Steroid; D020218:Response Elements / Q000502:physiology*; D054339:Steroidogenic Factor 1; D014157:Transcription Factors / Q000378:metabolism; D014162:Transfection; D014407:Tumor Cells, Cultured
D051836:COUP Transcription Factors; D004268:DNA-Binding Proteins; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D051717:Fushi Tarazu Transcription Factors; D018398:Homeodomain Proteins; D006728:Hormones; C515057:NR5A1 protein, human; D018160:Receptors, Cytoplasmic and Nuclear; D011960:Receptors, Estrogen; D011987:Receptors, Steroid; D054339:Steroidogenic Factor 1; D014157:Transcription Factors; C515060:steroidogenic factor 1, rat; D010121:Oxytocin